Literature DB >> 23473787

MiR-21 involve in ERK-mediated upregulation of MMP9 in the rat hippocampus following cerebral ischemia.

XiaHeng Deng1, Yun Zhong, LiZe Gu, Wei Shen, Jun Guo.   

Abstract

Matrix metallinoprotease-9 (MMP9) plays a key role in the pathogenesis of post-ischemic blood brain barrier (BBB) disruption and the formation of lesions after cerebral ischemia. In this study we investigate the effect of brain-specific miRNAs on MMP-9 protein level in the rat hippocampus following cerebral ischemia and its underlying mechanism. Cerebral ischemia significantly upregulated miR-21 and -224 in the hippocampus; however, expression of miR-122 and -338-3p was not significantly affected by ischemia. Silencing of miR-21, but not -224, reduced MMP9 protein level after cerebral ischemia. Downregulation of extracellular signal-regulated kinase (ERK) signaling using the ERK inhibitor U0126 and the calcium-channel blocker ketamine inhibited the upregulation of miR-21 expression and MMP9 protein level after cerebral ischemia. The study suggests that cerebral ischemia up-regulates expression level of miR-21, which is involved in ERK-stimulated upregulation of MMP9 following cerebral ischemia via a calcium-dependent mechanism.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23473787     DOI: 10.1016/j.brainresbull.2013.02.007

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  24 in total

Review 1.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

2.  The MicroRNA-224 Inhibitor Prevents Neuronal Apoptosis via Targeting Spastic Paraplegia 7 After Cerebral Ischemia.

Authors:  Feng Fu; Dingfeng Wu; Chao Qian
Journal:  J Mol Neurosci       Date:  2016-05-10       Impact factor: 3.444

Review 3.  MicroRNAs expression and function in cerebral ischemia reperfusion injury.

Authors:  Yu Di; Yang Lei; Feng Yu; Fan Changfeng; Wang Song; Mo Xuming
Journal:  J Mol Neurosci       Date:  2014-04-04       Impact factor: 3.444

Review 4.  The Emerging Role of Epigenetics in Cerebral Ischemia.

Authors:  Zhiping Hu; Bingwu Zhong; Jieqiong Tan; Chunli Chen; Qiang Lei; Liuwang Zeng
Journal:  Mol Neurobiol       Date:  2016-02-19       Impact factor: 5.590

Review 5.  Long noncoding RNAs: a new regulatory code in osteoarthritis.

Authors:  Xiao Cen; Xin-Qi Huang; Wen-Tian Sun; Qing Liu; Jun Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

6.  MiR-539 Targets MMP-9 to Regulate the Permeability of Blood-Brain Barrier in Ischemia/Reperfusion Injury of Brain.

Authors:  Feng Fan; Jiao Yang; Yuanjie Xu; Sheng Guan
Journal:  Neurochem Res       Date:  2018-10-01       Impact factor: 3.996

7.  Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression.

Authors:  Krassimira A Garbett; Andrea Vereczkei; Sára Kálmán; Jacquelyn A Brown; Warren D Taylor; Gábor Faludi; Željka Korade; Richard C Shelton; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2014-06-02       Impact factor: 13.382

8.  microRNA-21 Confers Neuroprotection Against Cerebral Ischemia-Reperfusion Injury and Alleviates Blood-Brain Barrier Disruption in Rats via the MAPK Signaling Pathway.

Authors:  Xiaofeng Yao; Yahui Wang; Dongya Zhang
Journal:  J Mol Neurosci       Date:  2018-04-26       Impact factor: 3.444

9.  MiRNAs are involved in chronic electroacupuncture tolerance in the rat hypothalamus.

Authors:  Luying Cui; Yi Ding; Yan Feng; Shuhuai Chen; Yingqing Xu; Meng Li; Manli Hu; Zhengying Qiu; Mingxing Ding
Journal:  Mol Neurobiol       Date:  2016-02-04       Impact factor: 5.590

10.  LncRSPH9-4 Facilitates Meningitic Escherichia coli-Caused Blood-Brain Barrier Disruption via miR-17-5p/MMP3 Axis.

Authors:  Bojie Xu; Ruicheng Yang; Jiyang Fu; Bo Yang; Jiaqi Chen; Chen Tan; Huanchun Chen; Xiangru Wang
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.